Insight - ‘Green’ recovery as companies restrategise

ESG trend: In terms of the environment - Duopharma Biotech is targeting a reduction of 5% in energy intensity on a yearly basis. ESG trend: In terms of the environment, Duopharma Biotech is targeting a reduction of 5% in energy intensity on a yearly basis.

AS companies restrategise their business models and operations, following the Covid-19 attack, a “green” recovery should be their top priority.

With intensified focus on environmental, social and governance (ESG) principles, the current thinking is to integrate them into the overall business strategy, down to the day-to-day operations.